Literature DB >> 19372031

Preliminary evidence for reduced frontal white matter integrity in subjects at ultra-high-risk for psychosis.

B D Peters, N Schmitz, P M Dingemans, T A van Amelsvoort, D H Linszen, L de Haan, C B Majoie, G J den Heeten.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19372031     DOI： 10.1016/j.schres.2009.03.018

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  14 in total

1.  Progressive structural brain changes during development of psychosis.

Authors:  Tim B Ziermans; Patricia F Schothorst; Hugo G Schnack; P Cédric M P Koolschijn; René S Kahn; Herman van Engeland; Sarah Durston
Journal:  Schizophr Bull       Date:  2010-10-07       Impact factor: 9.306

2.  White matter microstructure in individuals at clinical high risk of psychosis: a whole-brain diffusion tensor imaging study.

Authors:  Christian Clemm von Hohenberg; Ofer Pasternak; Marek Kubicki; Thomas Ballinger; Mai-Anh Vu; Tali Swisher; Katie Green; Michelle Giwerc; Brian Dahlben; Jill M Goldstein; Tsung-Ung W Woo; Tracey L Petryshen; Raquelle I Mesholam-Gately; Kristen A Woodberry; Heidi W Thermenos; Christoph Mulert; Robert W McCarley; Larry J Seidman; Martha E Shenton
Journal:  Schizophr Bull       Date:  2013-06-04       Impact factor: 9.306

3.  Extensive white matter abnormalities in patients with first-episode schizophrenia: a Diffusion Tensor Iimaging (DTI) study.

Authors:  Sang-Hyuk Lee; Marek Kubicki; Takeshi Asami; Larry J Seidman; Jill M Goldstein; Raquelle I Mesholam-Gately; Robert W McCarley; Martha E Shenton
Journal:  Schizophr Res       Date:  2013-01-03       Impact factor: 4.939

4.  Increased diffusivity in gray matter in recent onset schizophrenia is associated with clinical symptoms and social cognition.

Authors:  Jung Sun Lee; Chang-Yoon Kim; Yeon Ho Joo; Dominick Newell; Sylvain Bouix; Martha E Shenton; Marek Kubicki
Journal:  Schizophr Res       Date:  2016-08-21       Impact factor: 4.939

5.  Sleep dysfunction and thalamic abnormalities in adolescents at ultra high-risk for psychosis.

Authors:  Jessica R Lunsford-Avery; Joseph M Orr; Tina Gupta; Andrea Pelletier-Baldelli; Derek J Dean; Ashley K Smith Watts; Jessica Bernard; Zachary B Millman; Vijay A Mittal
Journal:  Schizophr Res       Date:  2013-10-04       Impact factor: 4.939

6.  Impaired Sensorimotor Gating Using the Acoustic Prepulse Inhibition Paradigm in Individuals at a Clinical High Risk for Psychosis.

Authors:  Qijing Bo; Zhen Mao; Qing Tian; Ningbo Yang; Xianbin Li; Fang Dong; Fuchun Zhou; Liang Li; Chuanyue Wang
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

7.  Altered Thalamo-Cortical White Matter Connectivity: Probabilistic Tractography Study in Clinical-High Risk for Psychosis and First-Episode Psychosis.

Authors:  Kang Ik K Cho; Martha E Shenton; Marek Kubicki; Wi Hoon Jung; Tae Young Lee; Je-Yeon Yun; Sung Nyun Kim; Jun Soo Kwon
Journal:  Schizophr Bull       Date:  2015-11-23       Impact factor: 9.306

8.  Alterations in white matter evident before the onset of psychosis.

Authors:  Francesco Carletti; James B Woolley; Sagnik Bhattacharyya; Rocio Perez-Iglesias; Paolo Fusar Poli; Lucia Valmaggia; Matthew R Broome; Elvira Bramon; Louise Johns; Vincent Giampietro; Steve C R Williams; Gareth J Barker; Philip K McGuire
Journal:  Schizophr Bull       Date:  2012-04-03       Impact factor: 9.306

Review 9.  Exploring predictors of outcome in the psychosis prodrome: implications for early identification and intervention.

Authors:  Tara A Niendam; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropsychol Rev       Date:  2009-07-14       Impact factor: 7.444

10.  Using structural neuroimaging to make quantitative predictions of symptom progression in individuals at ultra-high risk for psychosis.

Authors:  Stefania Tognin; William Pettersson-Yeo; Isabel Valli; Chloe Hutton; James Woolley; Paul Allen; Philip McGuire; Andrea Mechelli
Journal:  Front Psychiatry       Date:  2014-01-29       Impact factor: 4.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.